No name

Did you know that schizophrenia affects more than 1 percent of the world's population?

See NARSAD Grants at work on the latest schizophrenia research

Schizophrenia is a severe, chronic, and generally disabling brain and behavior disorder. It is most accurately described as a psychosis - a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be caused by a combination of genetic and environmental factors.

Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them. Negative symptoms may include avolition (a lack of desire or motivation to accomplish goals), lack of desire to form social relationships, and blunted affect and emotion. Cognitive symptoms involve problems with attention and memory, especially in planning and organization to achieve a goal. Cognitive deficits are the most disabling for patients trying to lead a normal life.

learn more about schizophrenia

Visit the Schizophrenia Research Forum, fully sponsored by the Brain & Behavior Research Foundation—a virtual community of scientists collaborating in their quest for causes, improved treatments, and better understanding of schizophrenia.

Visit the Schizophrenia Research Forum for more information about research


Op-Ed Piece from written by Dr. Jeffrey Borenstein, M.D.
March 17, 2013
On March 15th, Brain & Behavior Research Foundation President & CEO, Jeffrey Borenstein, M.D., contributed this article to Live Science's Expert Voices...
Jeffrey Borenstein, M.D., Brain & Behavior Research Foundation President and CEO
Jeffrey Borenstein, M.D.
March 15, 2013
The Board of Directors of the Brain & Behavior Research Foundation (formerly National Alliance for Research on Schizophrenia and Depression or NARSAD), a...
Jeffrey Borenstein, M.D.
Jeffrey Borenstein, M.D.
March 15, 2013
For immediate release: March 15, 2013 Contact:Sally Corbett,[email protected](Metro New York City/Great Neck, NY) The Board of Directors...
Transcranial Magnetic Stimulation used generally to treat depression, is now being used to treat schizophrenia symptoms
Transcranial Magnetic Stimulation
March 14, 2013
A team of researchers from the University of Toronto, led by Zafiris J. Daskalakis, M.D., Ph.D., FRCP(C), three-time NARSAD Grantee and Associate Professor in...
March 13, 2013
Contact: Sally Corbett [email protected] (Great Neck, NY – March 13, 2013) The Brain & Behavior Research Foundation (formerly NARSAD,...


Subscribe to